FDAClass II · Drug · Recall D-0610-2026 · Recalled June 24, 2026

Chlorthalidone Tablets recall — Inventia Healthcare Limited

Agency report date: June 24, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named: Chlorthalidone Tablets
Company / brand: Inventia Healthcare
Lot / serial / date codes: [100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027
Distribution: U.S. Nationwide.

Agency product description and boundaries

Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Dissolution Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Chlorthalidone Tablets

3. Open the official notice or contact

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0610-2026
Brand: Inventia Healthcare
Classification: Class II
Units affected: 11,460 bottles
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Affected products

Chlorthalidone Tablets

Companies & origin

Recalling firm location: Kalyan, India
Firm address: Additional Ambernath Midc, Ambernath East; F1-F1/1-F75/1, N/A

Identifying details (verbatim from the notice)

Product codes / lots: [100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027
Distribution: U.S. Nationwide.
Firm notified the public via: Letter
FDA event ID: 99136
Recall initiated: June 5, 2026
FDA classified: June 22, 2026
FDA report date: June 24, 2026

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page